HAOHAI BIOTEC (06826) shareholder Lou Guoliang intends to reduce his holdings by no more than 1.5 million shares.
Haohai Biotechnology (06826) announced that Mr. Lou Guoliang, due to his own financial needs, plans to...
HAOHAI BIOTEC (06826) announced that Mr. Lou Guoliang plans to reduce his shareholding in the company by a total of no more than 1.5 million shares, representing no more than 0.6432% of the total share capital of the company of 233,193,695 shares, within 3 months after 3 trading days from the date of this announcement, due to his own financial needs. This reduction will be carried out through a combination of centralized bidding and block trading, with up to 1.5 million shares to be reduced through centralized bidding and up to 1.5 million shares through block trading. The reduction price will be determined based on the secondary market price.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


